Efficacy of Buparvaquone Treatment in Pregnant Cows Infect with Theileria Species in Sudan
Asian Journal of Research in Animal and Veterinary Sciences,
A total of 100 pregnant cows from various private livestock farms of Al Nuba town, Al Gezira State, Sudan was selected to assess the therapeutic effect of buparvaquone in bovine theileriosis. Theileriosis was diagnosed before treatment by blood smears and PCR. Theileria spp. infected animals (n=96) were divided into three groups based on their gestation period; A (6 months, n=25), B (7 months, n=41) and C (8 months, n=30). Each group was subdivided into two subgroups; treated animals [T (n=68) including; TA (n=16), TB (n=28) and TC (n=24)] and non-treated animals [NT (n=28) including; NTA (n=9), NTB (n=13) and NTC (n=6)]. The subgroups TA, TB and TC were treated with buparvaquone at the dose rate of 2.5 mg/kg body weight intramuscularly. All cows were re-examined clinically and laboratory using blood smears and PCR four and six weeks after treatment. The overall recovered cows showed significant (P≤ 0.05) differences between treated and non-treated animals; the recovery percentages in treated animals (T) were 38.2% and 66.2% after 4 and 6 weeks of treatment, respectively, while in the non-treated groups (NT) the percentages were 0% and 39.3% after the same time. A variation in recovery percentage was observed among animals based on the gestation period; the recovery percentages were 18.7%, 32.1% and 58.3% after 4 weeks of treatment and 81.3%, 57.1% and 66.7% after 6 weeks of treatment for group TA, TB, and TC, respectively. The recovery percentage was 0% for NTA, NTB and NTC after 4 weeks and 33.3%, 38.5% and 50% after 6 weeks for the same groups. In conclusion, buparvaquone is quite effective against bovine theileriosis. However, it could be less effective between 6 and 8 months of pregnancy. The highest recovery percentage is found in cows in 8th and 6th months of gestation after 4 and 6 weeks of treatment, respectively.
- pregnant cows
How to Cite
Ali AEF, Radwan MEI. Molecular detection of Theileria annulata in Egyptian buffaloes and biochemical changes associated with particular oxidative changes. Adv. Life Sci. 2011;1(1):6-10.
Erdemir A, Aktas M, Dumanli N, Turgut-Balik D. Isolation, cloning and sequence analysis of the lactate dehydrogenase gene from Theileria annulata may lead to design of new anti Theilerial drugs. Veterinarni Medicina. 2012;57(10):559-567.
El Hussein AM, Hassan SM, Salih DA. Current situation of tropical theileriosis in the Sudan. Parasitol Res. 2012;111(2): 503-8.
AL-Hosary, AAT, Elsayed H, Ahmed LS. Oxidative stress and hematological profile in Theileria annulata cillinacly infected cattle before and after treatment. Assiut Vet. Med. J. 2015;61(144):123-129.
Mehlhorn H. Encyclopedia of parasitiology, 3rd ed. Springer-Verlag, New York. 2008; 1370-1372.
FAO. Ticks and tick-borne diseases control. A practical field manual. Rome: Food and Agricultural Organization of the United Nations. 1984;1-2:621.
Abaker IA, Salih DA, Haj LME, Ahmed RE, Osman MM, Ali AM. Prevalence of Theileria annulata in dairy cattle in Nyala, South Darfur State, Sudan. Vet World. 2017;10(12):1475-1480.
DOI: 10.14202/vetworld. 2017.1475-1480
Latif AA. Economic losses in exotic breeds of cattle due to theileriosis in the Sudan. In: Attelmanan AM, Kheir SM, editors. Tropical Theileriosis in the Sudan. Khartoum, Sudan: Proceedings of a workshop held at the Sudan Veterinary Association Residence. 1994;4-5.
Ahmed, Mohamed Abdalla Mohamed. Prevalence of Ticks (Acari: Ixodidae) and Theileria annulata Infection in Cattle in Gezira State, Sudan. MVSc. Thesis. U of K; 2015.
[Accessed 1 January 2020]
Available:http://khartoumspace.uofk.edu /handle/ 123456789 /17923
Erb KH, Mayer A, Kastner T, Sallet KE, Haberl H. The impact of industrial grain fed livestock production on food security: An extended literature review. Commissioned by Compassion in World Farming, The Tubney Charitable Trust and World Society for the Protection of Animals, UK. Vienna, Austria; 2012.
Abd Ellah MR, AL-Hosary AAT. Cattle Theileriosis: Effect on serum constituents, erythrocytes and platelets picture. Conference: XVth International Congress on Animal Hygiene, Animal Hygiene and Sustainable Livestock Production, Vienna, Austria. 2011;909-912.
Hashemi-Fesharki R. Chemotherapeutic value of parvaquone and buparvaquone against Theileria annulata infection of cattle. Res Vet Sci. 1991;50(2):204-7.
Dolan TT, Injairu R, Gisemba F, Maina JN, Mbadi G, Mbwiria GHM, et al. A clinical trial of Buparvaquone in the treatment of East Coast fever. Vet. Rec. 1992;130: 536–538.
Jabbar AS, Rintelen M, Schein E, Williams RO, Dobbelaere D. Effect of buparvaquone on expression of interleukin 2 receptors in Theileria annulata–infected cells. Parasitol. Res. 1992;78:285–290.
Al-Gaabary MH, Osman SA. Clinical, hematological and therapeutic studies on tropical theileriosis in water buffaloes (Bubalus bubalis) in Egypt. Vet. Parasitol. 2007;146(3-4):337–340.
Lizundia R, Werling D, Langsley G, Ralph SA. Theileria apicoplast as a target for chemotherapy. Antimicrob Agents Chemother. 2009;53(3):1213-7.
Sambrook J, Fritsch ER, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
d'Oliveira C, van der Weide M, Habela MA, Jacquiet P, Jongejan F. Detection of Theileria annulata in blood samples of carrier cattle by PCR. J Clin Microbiol. 1995;33(10):2665-9.
Gamal A, EL Hussein AM. Economic impact of theileriosis on a dairy farm in river Nile State. Sudan J. Vet. Sci. Anim. Husb. 2003;42(1-2):268-273.
El Hussein AR, Majid AM, Shawgi MH. Present status of tick-borne diseases in the Sudan. Country reports. Arch Inst Pasteur Tunis. 2004;81(1-4):31-34.
Hayati MA, Hassan SM, Hussein MO, El Haj LM, Abdel Gadir SO, Osman MM, et al. Prevalence of ticks (Acari: Ixodidae) and Theileria annulata infection in cattle in Gezira State, Sudan. Conference: Berlin, Germany, DFG German African Cooperation Project ATIVM-STVM, Free University; 2016.
Ali AM, Bakheit MA, Mukhtar MM, Hassan SM, Ahmed JS, Seitzer U. Epidemiology of Theileria annulata infection of dairy cattle in the Sudan using molecular techniques. Ann NY Acad Sci. 2006;1081: 471–472.
Uilenberg G. Theilerial species of domestic livestock. In: Irving AD, Cunningham MP, Young AS, editors. Advances in the Control of Theileriosis. Martinus Nijhoff Publishers; The Hague, Boston, London. 1981;4–37.
FAO. Ticks and tick-borne diseases control. The Sudan: Studies on important tick-borne diseases of cattle. Technical Report No. 2. AG: GCP/SUD/024/ DEN/Rome; 1983.
Muhammad G, Saqib M, Athar M, Khan MZ, Asi MN. Clinico-epidemiological and therapeutic aspects of bovine theileriosis. Pakistan Vet. J. 1999;19(2):64-71.
Qayyum M, Farooq U, Samad HA, Chauhdry HR. Prevalence, clinicoth-erapeutic and prophylactic studies on theileriosis in district Sahiwal (Pakistan). J Anim Plant Sci. 2010;20(4):266-270.
Muraguri GR, Kiara HK, McHardy N. Treatment of East Coast fever: A comparison of parvaquone and buparvaquone. Vet Parasitol. 1999;87(1): 25-37.
Mbwambo HA, Magwisha HB, Mfinanga JM. Evaluation of buparvaquone (BUTA-Kel KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam city, Tanzania. Vet Parasitol. 2006;139(1-3):67-73.
Hussain A, Khokar MA, Awan AH, Chauhdry MA. Efficacy of butalex (buparvaquone) in naturally affected cattle with Theileria annulata. Pakistan J. Vet. Res. 1990;3(1):6-8.
Rubin P. Fortnightly review: Drug treatment during pregnancy. BMJ. 1998; 317(7171):1503–1506.
Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Seminars in perinatology. 2015;39(7):512–519.
DOI: 10.1053/j. semperi.2015.08.003
Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33 (5):328-43.
Rubin PC. Prescribing in pregnancy. General principles. Br Med J. 1986; 293(6559):1415–1417.
Abstract View: 3281 times
PDF Download: 944 times